Fernando Abollo‐Jiménez

Expression of <i>MALT1</i> oncogene in hematopoietic stem/progenitor cells recapitulates the pathogenesis of human lymphoma in mice

Carolina Vicente‐Dueñas, Lorena Fontán, Inés González‐Herrero et al. · Proceedings of the National Academy of Sciences · 2012 · 76 citations · Full text

Medicine, Hematology, Oncology +17

A novel molecular mechanism involved in multiple myeloma development revealed by targeting MafB to haematopoietic progenitors

Carolina Vicente‐Dueñas, Isabel Romero-Camarero, Inés González‐Herrero et al. · The EMBO Journal · 2012 · 68 citations · Full text

Medicine, Cell Biology, Hematology +13

Dysregulated splicing factor SF3B1 unveils a dual therapeutic vulnerability to target pancreatic cancer cells and cancer stem cells with an anti-splicing drug

Emilia Alors‐Pérez, Ricardo Blázquez‐Encinas, Sonia Alcalá et al. · Journal of Experimental & Clinical Cancer Research · 2021 · 58 citations · Full text

Medicine, Cancer Biology, Oncology +17

FUS-DDIT3 Prevents the Development of Adipocytic Precursors in Liposarcoma by Repressing PPARγ and C/EBPα and Activating eIF4E

Pedro A. Pérez–Mancera, Camino Bermejo‐Rodríguez, Manuel Sánchez‐Martín et al. · PLoS ONE · 2008 · 54 citations · Full text

Life Sciences, Genetics, Molecular Biology +17

Activating mutations in BRAF disrupt the hypothalamo-pituitary axis leading to hypopituitarism in mice and humans

Angelica Gualtieri, Nikolina Kyprianou, Louise Gregory et al. · Nature Communications · 2021 · 41 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17